China Cholesterol Test Market

ID: MRFR/HC/49399-HCR 200 Pages Satyendra Maurya Last Updated: September 17, 2026
China Cholesterol Test Market Research Report: Size, Share, Trend Analysis By Product Type (Test Kits, Test Strips), By Test Type (Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL), Cholesterol and Triglycerides/VLDL Cholesterol Test), By Distribution Channel (Over the Counter, Prescription Based) and By End-User (Hospitals & Clinics, Homecare, Diagnostic Centers) - Growth Outlook & Industry Forecast 2025 To 2035
China Cholesterol Test Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)8.32%
2024 Market Size$ 544.31 Million
2025 Market Size$ 589.6 Million
2035 Market Size$ 1,310.6 Million
Key Players
Abbott Laboratories
Roche Diagnostics
Siemens Healthineers
Thermo Fisher Scientific
Danaher Corporation
Bayer AG
Opportunities
  • Growing Aging Population
  • Rising Healthcare Expenditure
  • Rising Demand for Home Testing Kits
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Product Type (USD Million)
      1. 4.1.1 Test Kits
      2. 4.1.2 Test Strips
    2. 4.2 Construction, BY Test Type (USD Million)
      1. 4.2.1 Total Cholesterol Test
      2. 4.2.2 High-Density Lipoprotein (HDL) Cholesterol
      3. 4.2.3 Low-Density Lipoprotein (LDL)
      4. 4.2.4 Cholesterol and Triglycerides/VLDL Cholesterol Test
    3. 4.3 Construction, BY Distribution Channel (USD Million)
      1. 4.3.1 Over the Counter
      2. 4.3.2 Prescription Based
    4. 4.4 Construction, BY End-User (USD Million)
      1. 4.4.1 Hospitals & Clinics
      2. 4.4.2 Homecare
      3. 4.4.3 Diagnostic Centers
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Abbott Laboratories (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche Diagnostics (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Thermo Fisher Scientific (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Danaher Corporation (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Bayer AG (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 PerkinElmer (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Acon Laboratories (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 CHINA MARKET ANALYSIS BY TEST TYPE
    4. 6.4 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    5. 6.5 CHINA MARKET ANALYSIS BY END-USER
    6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CONSTRUCTION
    9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
    12. 6.12 CONSTRUCTION, BY PRODUCT TYPE, 2024 (% SHARE)
    13. 6.13 CONSTRUCTION, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 CONSTRUCTION, BY TEST TYPE, 2024 (% SHARE)
    15. 6.15 CONSTRUCTION, BY TEST TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 CONSTRUCTION, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    17. 6.17 CONSTRUCTION, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    18. 6.18 CONSTRUCTION, BY END-USER, 2024 (% SHARE)
    19. 6.19 CONSTRUCTION, BY END-USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY TEST TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
      4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Cholesterol Test Market Segmentation

China Cholesterol Test Market By Product Type (USD Million, 2025-2035)

  • Test Kits
  • Test Strips

China Cholesterol Test Market By Test Type (USD Million, 2025-2035)

  • Total Cholesterol Test
  • High-Density Lipoprotein (HDL) Cholesterol
  • Low-Density Lipoprotein (LDL)
  • Cholesterol and Triglycerides/VLDL Cholesterol Test

China Cholesterol Test Market By Distribution Channel (USD Million, 2025-2035)

  • Over the Counter
  • Prescription Based

China Cholesterol Test Market By End-User (USD Million, 2025-2035)

  • Hospitals & Clinics
  • Homecare
  • Diagnostic Centers
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.